levamlodipine

Trade name: Conjupri

Small moleculeapproved

Approved

Dec 19, 2019

Levalmodipine (S-amlodipine) is an active enantiomer of amlodipine, a calcium antagonist that inhibits the transmembrane influx of calcium ions into vascular smooth muscle and cardiac muscle. Experimental data suggest that S-amlodipine binds to both dihydropyridine and nondihydropyridine binding sites. The contractile processes of cardiac muscle and vascular smooth muscle are dependent upon the movement of extracellular calcium ions into these cells through specific ion channels. S-Amlodipine inhibits calcium ion influx across cell membranes selectively, with a greater effect on vascular smooth muscle cells than on cardiac muscle cells. Enantiomerically pure S-amlodipine is marketed in some countries worldwide, while racemate, containing active S-enantiomer an inactive R-enantiomer is marketed in the USA and indicated for the treatment of hypertension and coronary artery disease. — NCATS

Clinical trial activity

14 trials · 23 clinical orgs · 1 marketing orgs

Phase 1
5
Phase 2
6
Phase 3
6
Phase 4
2

Earliest trial started Jan 1, 2006 (NCT00289406)

Timeline

2000s

  1. Jan 1, 2006

    Earliest Phase 3 Sponsor(trial)

2010s

  1. Jan 1, 2010

    Earliest Phase 2 Sponsor(trial)

  2. Jan 1, 2011

    Earliest Phase 1 Sponsor(trial)

  3. Dec 19, 2019

    Shijiazhuang Pharma Group (CSPC) — Earliest FDA Approval

  4. Dec 19, 2019

    Shijiazhuang Pharma Group (CSPC) — Marketing Organization

  5. Dec 19, 2019

    Shijiazhuang Pharma Group (CSPC) — NDA Organization

Indications

Mechanism of action

Approval history

  • approvedDec 19, 2019

Chemistry & pharmacology

Loading structure…

SMILES

CCOC(=O)C1=C(COCCN)NC(C)=C([C@@H]1C2=CC=CC=C2Cl)C(=O)OC
Mol. weight
408.876 g/mol
Lipinski Ro5
Pass
Rule of 3
No
Chirality
Single Stereoisomer
Inorganic
No
Polymer
No
Delivery
Oral
Availability
Discontinued

Oral

Yes

Parenteral

No

Topical

No

Sources

Also known as

  • 2-((2-aminoethoxy)methyl)-4-(2-chlorophenyl)-3-ethoxy-carbonyl-5-methoxycarbonyl-6-methyl-1,4-dihydropyridine
  • l-amlodipine
  • levamlodipine
  • levamlodipine
  • levamlodipine
  • levamlodipine
  • levamlodipine
  • levamlodipine besylate
  • levamlodipine besylate
  • levamlodipine besylate
  • levamlodipine malate
  • levamlodipine malate
  • levoamlodipine
  • levoamlodipine
  • levoamlodipine
  • (s)-amlodipine
  • s-amlodipine
  • s-amlodipine
  • s-amlodipine
  • s-amlodipine gentisate
  • s-amlodipine gentisate

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT06771245Phase 3Jan 24, 2025Shijiazhuang Pharma Group (CSPC)
NCT04411875Phase 1Nov 13, 2018Qingdao University
NCT03657550Phase 1May 31, 2018Yiling Pharmaceutical Inc.
NCT02358824Phase 1Feb 1, 2015Chong Kun Dang Pharmaceutical, Kyungpook University
NCT02250833Phase 1Sep 1, 2014Chong Kun Dang Pharmaceutical, Kyungpook University
NCT01983735Phase 3Jan 1, 2014Chong Kun Dang Pharmaceutical
NCT03038451Phase 4Mar 20, 2013NeuTec Pharma
NCT01634295Phase 3Jul 1, 2012Catholic University of Korea, Chong Kun Dang Pharmaceutical, Dong-A University, Ewha Womans University, Gachon University, Hallym University, Konyang University, Korea University, Kyung Hee University, Seoul National University, Yonsei University
NCT01501253Phase 3Aug 1, 2011Catholic University of Korea, Chong Kun Dang Pharmaceutical
NCT01356043Phase 1May 1, 2011Chong Kun Dang Pharmaceutical, University of Ulsan
NCT01128322Phase 2Jul 1, 2010Chong Kun Dang Pharmaceutical
NCT04740840Phase 2/Phase 3 (Phase 3)May 1, 2010North Sichuan Medical University, People's Liberation Army of China
NCT01131546Phase 4Dec 1, 2009Fudan University, Peking University, Simcere Pharmaceutical Co., Ltd
NCT00289406Phase 3Jan 1, 2006SK Chemicals
Showing 14 of 14 trials
Page 1 / 1

Organizations

Research & Development (23)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
Chong Kun Dang PharmaceuticalFor profit7732010
Catholic University of KoreaAcademic/Hospital2012011
Kyungpook UniversityAcademic/Hospital2012014
Dong-A UniversityAcademic/Hospital1012012
Ewha Womans UniversityAcademic/Hospital1012012
Fudan UniversityAcademic/Hospital1012009
Gachon UniversityAcademic/Hospital1012012
Hallym UniversityAcademic/Hospital1012012
Konyang UniversityAcademic/Hospital1012012
Korea UniversityAcademic/Hospital1012012
Kyung Hee UniversityAcademic/Hospital1012012
NeuTec PharmaFor profit1112013
North Sichuan Medical UniversityAcademic/Hospital1112010
Peking UniversityAcademic/Hospital1012009
People's Liberation Army of ChinaGovernment1012010
Qingdao UniversityAcademic/Hospital1112018
Seoul National UniversityAcademic/Hospital1012012
Shijiazhuang Pharma Group (CSPC)For profit1112025
Simcere Pharmaceutical Co., LtdFor profit1112009
SK ChemicalsFor profit1112006
23 organizations
Page 1 / 2

Marketing (3)

OrganizationOrg typeRelationshipDate
Shijiazhuang Pharma Group (CSPC)For profitMKTGDec 19, 2019
Shijiazhuang Pharma Group (CSPC)For profitSYNDec 19, 2019
Shijiazhuang Pharma Group (CSPC)For profitNDADec 19, 2019